Steven Maron
Overview
Explore the profile of Steven Maron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klemen N, Court C, Fernandes M, Walch H, Chatila W, Saadat L, et al.
Ann Surg Oncol
. 2022 Aug;
29(13):8373-8382.
PMID: 35930112
Background: Immune checkpoint blockade (ICI) of programmed cell death protein 1 (PD-1) or PD-1 ligand (PD-L1) can induce durable responses in patients who have colorectal cancer (CRC) with a high...
2.
Sihag S, Nussenzweig S, Walch H, Hsu M, Tan K, Sanchez-Vega F, et al.
Clin Cancer Res
. 2021 Apr;
27(12):3491-3498.
PMID: 33795256
Purpose: To delineate recurrent oncogenic driver alterations and dysregulated pathways in esophageal adenocarcinoma and to assess their prognostic value. Experimental Design: We analyzed a large cohort of patients with lower...
3.
Kundra R, Zhang H, Sheridan R, Sirintrapun S, Wang A, Ochoa A, et al.
JCO Clin Cancer Inform
. 2021 Feb;
5:221-230.
PMID: 33625877
Purpose: Cancer classification is foundational for patient care and oncology research. Systems such as International Classification of Diseases for Oncology (ICD-O), Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), and National...
4.
5.
Pectasides E, Stachler M, Derks S, Liu Y, Maron S, Islam M, et al.
Cancer Discov
. 2017 Oct;
8(1):37-48.
PMID: 28978556
Gastroesophageal adenocarcinoma (GEA) is a lethal disease where targeted therapies, even when guided by genomic biomarkers, have had limited efficacy. A potential reason for the failure of such therapies is...
6.
Wadia R, Yao X, Deng Y, Li J, Maron S, Connery D, et al.
Cancer Med
. 2015 Jun;
4(9):1365-73.
PMID: 26063243
There are limited data on the impact of mental health comorbidities (MHC) on stage at diagnosis and timeliness of cancer care. Axis I MHC affect approximately 30% of Veterans receiving...
7.